nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A message from the new editor-in-chief
|
Nishimura, Yasumasa |
|
|
25 |
5 |
p. 785-786 |
artikel |
2 |
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-
|
Kasai, Takashi |
|
|
25 |
5 |
p. 867-875 |
artikel |
3 |
Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience
|
Ito, Katsuhiro |
|
|
25 |
5 |
p. 906-911 |
artikel |
4 |
Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments
|
Sassa, Naoto |
|
|
25 |
5 |
p. 929-936 |
artikel |
5 |
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan
|
Narita, Shintaro |
|
|
25 |
5 |
p. 912-920 |
artikel |
6 |
Combination therapy with PD-1 or PD-L1 inhibitors for cancer
|
Hayashi, Hidetoshi |
|
|
25 |
5 |
p. 818-830 |
artikel |
7 |
Current issues and perspectives in PD-1 blockade cancer immunotherapy
|
Chamoto, Kenji |
|
|
25 |
5 |
p. 790-800 |
artikel |
8 |
Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology
|
Saito, Ryoichi |
|
|
25 |
5 |
p. 831-841 |
artikel |
9 |
High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
|
Tan, Joey Wee-Shan |
|
|
25 |
5 |
p. 984-994 |
artikel |
10 |
Immune-resistant mechanisms in cancer immunotherapy
|
Kawakami, Yutaka |
|
|
25 |
5 |
p. 810-817 |
artikel |
11 |
Laparoscopic versus abdominal radical hysterectomy for stage IB1 cervical cancer patients with tumor size ≤ 2 cm: a case-matched control study
|
Chen, Chunlin |
|
|
25 |
5 |
p. 937-947 |
artikel |
12 |
Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis
|
Abdel-Rahman, Omar |
|
|
25 |
5 |
p. 885-891 |
artikel |
13 |
Magnitude of advantage in tumor response contributes to a better correlation between treatment effects on overall survival and progression-free survival: a literature-based meta-analysis of clinical trials in patients with metastatic colorectal cancer
|
Yoshida, Yosuke |
|
|
25 |
5 |
p. 851-860 |
artikel |
14 |
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma
|
Nomura, Motoo |
|
|
25 |
5 |
p. 972-977 |
artikel |
15 |
Operation for locally advanced cervical cancer after concurrent chemoradiotherapy
|
Ge, Junli |
|
|
25 |
5 |
p. 948-954 |
artikel |
16 |
Outcome of patients with primary retroperitoneal solitary fibrous sarcoma
|
Luo, Peng |
|
|
25 |
5 |
p. 921-928 |
artikel |
17 |
Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study
|
Taguchi, Ayumi |
|
|
25 |
5 |
p. 955-962 |
artikel |
18 |
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution
|
Takagi, Toshio |
|
|
25 |
5 |
p. 892-898 |
artikel |
19 |
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
|
Tamura, Daichi |
|
|
25 |
5 |
p. 899-905 |
artikel |
20 |
Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma
|
Ozeki, Naoki |
|
|
25 |
5 |
p. 876-884 |
artikel |
21 |
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
|
Sato, Hiro |
|
|
25 |
5 |
p. 801-809 |
artikel |
22 |
Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment
|
Kunitake, Teruyo |
|
|
25 |
5 |
p. 963-971 |
artikel |
23 |
Safety of radiotherapy for hemodialysis patients with cancer
|
Hirota, Hiroshi |
|
|
25 |
5 |
p. 978-983 |
artikel |
24 |
Toward a new stage of PD-1 blockade cancer immunotherapy
|
Minato, Nagahiro |
|
|
25 |
5 |
p. 787-789 |
artikel |
25 |
Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study
|
Abdel-Rahman, Omar |
|
|
25 |
5 |
p. 861-866 |
artikel |
26 |
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract
|
Morita, Masaru |
|
|
25 |
5 |
p. 842-850 |
artikel |